Delivery Order SPE2DE24D0013-SPE2D626F29P0
- Not listed
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $27,650.40 by the Defense Logistics Agency Medical Supply Chain on November 13, 2025. This firm fixed-price delivery order, designated XPRSMVP-10 with completion targeted for November 20, 2025, represents a procurement of diagnostic testing supplies and reagents under an existing indefinite delivery contract vehicle. The award carries no set-aside designation,...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on December 2, 2025, under contract 4570154100 (XPRS4PLEX-10) with an ultimate completion date of December 9, 2025. This delivery order, which received no set-aside designation, is for diagnostic testing supplies and reagents to be delivered to the place of performance in Sunnyvale, California. Cepheid, a leading federal supplier of molecular diagnostic systems headquartered in...
- Cepheid Inc., a molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,440 on December 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by December 12, 2025, and will be performed at the contractor's Sunnyvale facility. The award carries no set-aside designation, reflecting Cepheid's competitive positioning in...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,720 on October 29, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic testing supplies and reagents. The delivery order, designated as XPRS4PLEX-10, is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and no set-aside designation. This award falls under Cepheid's broader contracting...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $15,552.00 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 24, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, involves the supply of molecular diagnostic reagents and test kits for the GeneXpert diagnostic platform. The award carries no set-aside designation, reflecting Cepheid's competitive positioning as an...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- The Defense Logistics Agency's Medical Supply Chain awarded a $1,440 firm fixed-price delivery order to Cepheid Inc. on December 1, 2025, with an ultimate completion date of December 8, 2025. This delivery order, issued under contract number 4570137197, represents a procurement of molecular diagnostic supplies or reagents from Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic testing systems. The award carries no set-aside designation, reflecting Cepheid's...
- Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California, was awarded a delivery order valued at $5,099.70 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRS4PLEX-10, represents procurement of diagnostic reagents and test kits—specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform. The contract...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $15,456 by the Defense Logistics Agency Medical Supply Chain on December 9, 2025, with an ultimate completion date of December 16, 2025. This firm fixed-price delivery order, designated XPRSTREPA-10, carries no set-aside designation and represents procurement under Cepheid's established contracting relationship with the Defense Logistics Agency for...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F29P0Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $4,080 to Cepheid Inc. on December 16, 2025, with an ultimate completion date of December 23, 2025. This delivery order, issued under contract 4570311572 (XPRS4PLEX-10), carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. The award represents procurement of diagnostic testing supplies and reagents, consistent with Cepheid's established role as a primary federal supplier of molecular diagnostic solutions and GeneXpert diagnostic platform components to the Defense Health Agency and other federal healthcare entities. Cepheid Inc. is a specialized manufacturer of advanced molecular diagnostic systems and reagents headquartered in Sunnyvale, California, with extensive federal contracting experience across the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with the VA valued at approximately $6.7 million and $32.8 million through 2029–2030, which establish the framework for ongoing procurement of diagnostic reagents and test kits across federal healthcare facilities. This delivery order falls within the broader context of Cepheid's established federal supplier relationships and its core competency in providing rapid molecular diagnostic testing solutions for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and tuberculosis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/15/25 |